These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35307769)

  • 1. Correction to: Position statement of the Spanish society of pediatric rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: part 1 (screening).
    Núñez Cuadros E; Calzada-Hernández J; Clemente D; Martín SG; Fernández Silveira L; Lirola-Cruz MJ; Tagarro A; Camacho Lovillo M; Alcobendas Rueda RM; López López A; Satrustegi Aritziturri M; Calvo C
    Eur J Pediatr; 2022 Jun; 181(6):2355. PubMed ID: 35307769
    [No Abstract]   [Full Text] [Related]  

  • 2. Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening).
    Cuadros EN; Calzada-Hernández J; Clemente D; Martín SG; Silveira LF; Lirola-Cruz MJ; Tagarro A; Lovillo MC; Rueda RMA; López AL; Aritziturri MS; Calvo C
    Eur J Pediatr; 2022 Jun; 181(6):2343-2354. PubMed ID: 35258699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases.
    Kobayashi I; Mori M; Yamaguchi K; Ito S; Iwata N; Masunaga K; Shimojo N; Ariga T; Okada K; Takei S
    Mod Rheumatol; 2015 May; 25(3):335-43. PubMed ID: 25381726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position paper from the Spanish Society of Rheumatology on biosimilar drugs.
    Abad Hernández MÁ; Andreu JL; Caracuel Ruiz MÁ; Belmonte Serrano MÁ; Díaz-González F; Moreno Muelas JV
    Reumatol Clin; 2015; 11(5):269-78. PubMed ID: 25982595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.
    Uziel Y; Moshe V; Onozo B; Kulcsár A; Tróbert-Sipos D; Akikusa JD; Salviato Pileggi G; Maritsi D; Kasapcopur O; Rodrigues M; Smerla R; Rigante D; Makay B; Atsali E; Wulffraat N; Toplak N;
    Vaccine; 2020 Feb; 38(9):2198-2201. PubMed ID: 31987692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination Against SARS-CoV-2 in Immunosuppressed Patients with Rheumatic Diseases: Position Statement of the Greek Rheumatology Society.
    Greek Rheumatology Society and Professional Association of Rheumatologists (ERE-EPERE)
    Mediterr J Rheumatol; 2020 Dec; 31(4):430-432. PubMed ID: 33521579
    [No Abstract]   [Full Text] [Related]  

  • 7. Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset.
    Calvo I; Antón J; Bustabad S; Camacho M; de Inocencio J; Gamir ML; Graña J; La Cruz L; Robledillo JC; Medrano M; Merino R; Modesto C; Nuñez E; Rua MJ; Torrente-Segarra V; Vargas C; Carmona L; Loza E
    Rheumatol Int; 2015 Oct; 35(10):1615-24. PubMed ID: 25917856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of vaccinations and prophylaxis in rheumatic diseases.
    Papadopoulou D; Tsoulas C; Tragiannidis A; Sipsas NV
    Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):306-18. PubMed ID: 26362746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients].
    Gómez Reino J; Loza E; Andreu JL; Balsa A; Batlle E; Cañete JD; Collantes Estévez E; Fernández Carballido C; Fernández Sueiro JL; García de Vicuña R; González-Álvaro I; González Fernández C; Juanola X; Linares LF; Marenco JL; Martín Mola E; Moreno Ramos M; Mulero Mendoza J; Muñoz Fernández S; Queiro R; Richi Alberti P; Sanz J; Tornero Molina J; Zarco Montejo P; Carmona L;
    Reumatol Clin; 2011; 7(5):284-98. PubMed ID: 21925444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosimilars: complements and comments on the recent statement of the SFR and CRI. Comment on: "Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)." Schaeverbeke et al. Joint Bone Spine 2018;95:399-402.
    Cohen JD; Tropé S; Munos A; Bocquet F
    Joint Bone Spine; 2019 Mar; 86(2):287-288. PubMed ID: 30394338
    [No Abstract]   [Full Text] [Related]  

  • 11. Position Statement: A Pragmatic Approach for Medical Cannabis and Patients with Rheumatic Diseases.
    Fitzcharles MA; Niaki OZ; Hauser W; Hazlewood G;
    J Rheumatol; 2019 May; 46(5):532-538. PubMed ID: 30647183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatic fever: a multicenter study in the state of São Paulo. Pediatric Committee--São Paulo Pediatric Rheumatology Society.
    da Silva CH
    Rev Hosp Clin Fac Med Sao Paulo; 1999; 54(3):85-90. PubMed ID: 10668278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
    Niehues T; Horneff G; Michels H; Höck MS; Schuchmann L; ;
    Rheumatol Int; 2005 Apr; 25(3):169-78. PubMed ID: 15688190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structural quality of rheumatology clinics for children and adolescents. Paper by a task force of the "Society of Pediatric and Adolescent Rheumatology" and of the "Association of Rheumatology Clinics in Germany"].
    Michels H; Ganser G; Dannecker G; Forster J; Häfner R; Horneff G; Küster RM; Lakomek HJ; Lehmann H; Minden K; Rogalski B; Schöntube M; ;
    Z Rheumatol; 2006 Jul; 65(4):315-22, 324-6. PubMed ID: 16710651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience.
    Peña-Sagredo JL; Hernández MV; Fernandez-Llanio N; Giménez-Ubeda E; Muñoz-Fernandez S; Ortiz A; Gonzalez-Gay MA; Fariñas MC;
    Clin Exp Rheumatol; 2008; 26(5):854-9. PubMed ID: 19032819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current information about vaccination practice in pediatric rheumatic diseases and recommendations for future applications.
    Açarı C; Ünsal E
    Turk J Pediatr; 2017; 59(4):357-368. PubMed ID: 29624215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of new referrals to a single pediatric rheumatology center in Turkey.
    Karadağ ŞG; Sönmez HE; Tanatar A; Çakmak F; Çakan M; Ayaz NA
    Rheumatol Int; 2020 Feb; 40(2):313-321. PubMed ID: 31440813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of infectious complications in rheumatic disease patients: immunization, Pneumocystis carinii prophylaxis, and screening for latent infections.
    Singer NG; McCune WJ
    Curr Opin Rheumatol; 1999 May; 11(3):173-8. PubMed ID: 10328575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against SARS-CoV-2 in inflammatory rheumatic diseases : Recommendations of the German Society for Rheumatology for physicians and patients].
    Specker C; ; Schulze-Koops H;
    Z Rheumatol; 2021 Feb; 80(1):43-44. PubMed ID: 33438061
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric Rheumatology Collaborative Study Group - over four decades of pivotal clinical drug research in pediatric rheumatology.
    Brunner HI; Rider LG; Kingsbury DJ; Co D; Schneider R; Goldmuntz E; Onel KB; Giannini EH; Lovell DJ;
    Pediatr Rheumatol Online J; 2018 Jul; 16(1):45. PubMed ID: 29996857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.